Literature DB >> 17888143

Sulphonylurea treatment does not improve psychomotor development in children with KCNJ11 mutations causing permanent neonatal diabetes mellitus accompanied by developmental delay and epilepsy (DEND syndrome).

Z Sumnik, S Kolouskova, J K H Wales, V Komarek, O Cinek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17888143     DOI： 10.1111/j.1464-5491.2007.02228.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN： 0742-3071            Impact factor:   4.359


× No keyword cloud information.
  9 in total

Review 1.  Neonatal diabetes mellitus: a model for personalized medicine.

Authors:  Siri Atma W Greeley; Susan E Tucker; Rochelle N Naylor; Graeme I Bell; Louis H Philipson
Journal:  Trends Endocrinol Metab       Date:  2010-04-29       Impact factor: 12.015

Review 2.  Current understanding of K ATP channels in neonatal diseases: focus on insulin secretion disorders.

Authors:  Yi Quan; Andrew Barszczyk; Zhong-ping Feng; Hong-shuo Sun
Journal:  Acta Pharmacol Sin       Date:  2011-05-23       Impact factor: 6.150

Review 3.  K(ATP) channelopathies in the pancreas.

Authors:  Maria S Remedi; Joseph C Koster
Journal:  Pflugers Arch       Date:  2009-11-18       Impact factor: 3.657

Review 4.  Monogenic diabetes: a gateway to precision medicine in diabetes.

Authors:  Haichen Zhang; Kevin Colclough; Anna L Gloyn; Toni I Pollin
Journal:  J Clin Invest       Date:  2021-02-01       Impact factor: 14.808

Review 5.  Genetics and pathophysiology of neonatal diabetes mellitus.

Authors:  Rochelle N Naylor; Siri Atma W Greeley; Graeme I Bell; Louis H Philipson
Journal:  J Diabetes Investig       Date:  2011-06-05       Impact factor: 4.232

6.  First case of neonatal diabetes with KCNJ11 Q52R mutation successfully switched from insulin to sulphonylurea treatment.

Authors:  Sorin Ioacara; Sarah Flanagan; Elke Fröhlich-Reiterer; Robin Goland; Simona Fica
Journal:  J Diabetes Investig       Date:  2017-02-16       Impact factor: 4.232

Review 7.  Neonatal Diabetes and the KATP Channel: From Mutation to Therapy.

Authors:  Frances M Ashcroft; Michael C Puljung; Natascia Vedovato
Journal:  Trends Endocrinol Metab       Date:  2017-03-03       Impact factor: 12.015

8.  Permanent Neonatal Diabetes in a Patient with a KCNJ11/Q52R Mutation Accompanied by Intermittent Hypoglycemia and Liver Failure.

Authors:  Natalie D Shaw; Joseph A Majzoub
Journal:  Int J Pediatr Endocrinol       Date:  2009-10-08

9.  Novel perspectives of super-high dose sulfonylurea and high-dose oral prednisolone in an infant with DEND syndrome due to V64M heterozygote KCNJ11 mutation.

Authors:  Galia Barash; Haim Bassan; Ayelet Livne; Lilach Benyamini; Eli Heyman; Pamela Bowman; Marianna Rachmiel
Journal:  Acta Diabetol       Date:  2021-07-16       Impact factor: 4.280
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.